Related Experiment Video
Updated: Jun 13, 2026

15:04
Rejection of Fluorescence Background in Resonance and Spontaneous Raman Microspectroscopy
Published on: May 18, 2011
13.5K
Feasibility of diffuse Raman spectroscopy to detect in-vivo molecular changes in the tissue induced by subcutaneous
Max Dooley1, Jeni Luckett2, Nga Tsing Tang1
1School of Physics and Astronomy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Biomedical Optics Express
|December 10, 2025
Summary
Diffuse Raman spectroscopy (DRS) can detect molecular changes in tissue caused by the foreign body response (FBR) to biomaterials. This technique allows for in-vivo monitoring of FBR, aiding new biomaterial design and clinical monitoring.
Area of Science:
- Biomedical Engineering
- Materials Science
- Spectroscopy
Background:
- Biomaterials elicit host immune responses, known as foreign body responses (FBR).
- Detecting FBR-induced molecular changes in tissue is crucial for biomaterial development.
- Current methods often require animal sacrifice for histological assessment.
Purpose of the Study:
- To investigate the feasibility of using diffuse Raman spectroscopy (DRS) for in-vivo detection of molecular changes in subcutaneous tissue.
- To assess DRS's ability to monitor FBR in response to implanted biomaterials.
Main Methods:
- A mouse model with subcutaneous polyethylene terephthalate (PET) fiber implantation was used.
- Numerical modeling optimized DRS for detecting collagen deposition, a marker of FBR.
- In-situ and in-vivo DRS measurements were performed at various time points post-implantation.
Main Results:
- Post-mortem measurements showed a correlation between the 930 cm⁻¹ Raman band intensity (collagen) and FBR levels.
- In-vivo DRS spectra from live mice also demonstrated this correlation.
- Histology confirmed the FBR-induced collagen deposition.
Conclusions:
- In-vivo DRS is feasible for detecting molecular changes associated with FBR in subcutaneous tissue.
- This technique enables longitudinal FBR monitoring in individual animals, reducing the need for sacrifice.
- DRS shows potential for clinical monitoring of FBR in implant applications.

